Skip to main content
Log in

Biomarker-guided HF care: greater QOL improvement

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Bhardwaj A, et al. Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study. American Heart Journal 164: 793-799, No. 5, Nov 2012. Available from: URL: http://dx.doi.org/10.1016/j.ahj.2012.08.015

Download references

Additional information

* ProBNP Outpatient Tailored Chronic Heart Failure therapy, partially funded by Roche Diagnostics Corporation

Rights and permissions

Reprints and permissions

About this article

Cite this article

Biomarker-guided HF care: greater QOL improvement. PharmacoEconomics & Outcomes News 668, 9 (2012). https://doi.org/10.1007/s40274-012-0028-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-012-0028-4

Navigation